Table of Contents 1 Study Coverage 1.1 Antidiabetic Thiazolidinediones Product 1.2 Key Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Antidiabetic Thiazolidinediones Market Size Growth Rate by Type 1.4.2 Rosiglitazone 1.4.3 Pioglitazone 1.5 Market by Application 1.5.1 Global Antidiabetic Thiazolidinediones Market Size Growth Rate by Application 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Antidiabetic Thiazolidinediones Market Size 2.1.1 Global Antidiabetic Thiazolidinediones Revenue 2016-2025 2.1.2 Global Antidiabetic Thiazolidinediones Sales 2016-2025 2.2 Antidiabetic Thiazolidinediones Growth Rate by Regions 2.2.1 Global Antidiabetic Thiazolidinediones Sales by Regions 2.2.2 Global Antidiabetic Thiazolidinediones Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Antidiabetic Thiazolidinediones Sales by Manufacturers 3.1.1 Antidiabetic Thiazolidinediones Sales by Manufacturers 3.1.2 Antidiabetic Thiazolidinediones Sales Market Share by Manufacturers 3.1.3 Global Antidiabetic Thiazolidinediones Market Concentration Ratio (CR5 and HHI) 3.2 Antidiabetic Thiazolidinediones Revenue by Manufacturers 3.2.1 Antidiabetic Thiazolidinediones Revenue by Manufacturers (2016-2018) 3.2.2 Antidiabetic Thiazolidinediones Revenue Share by Manufacturers (2016-2018) 3.3 Antidiabetic Thiazolidinediones Price by Manufacturers 3.4 Antidiabetic Thiazolidinediones Manufacturing Base Distribution, Product Types 3.4.1 Antidiabetic Thiazolidinediones Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Antidiabetic Thiazolidinediones Product Category 3.4.3 Date of International Manufacturers Enter into Antidiabetic Thiazolidinediones Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type 4.1 Global Antidiabetic Thiazolidinediones Sales by Type 4.2 Global Antidiabetic Thiazolidinediones Revenue by Type 4.3 Antidiabetic Thiazolidinediones Price by Type 5 Breakdown Data by Application 5.1 Overview 5.2 Global Antidiabetic Thiazolidinediones Breakdown Data by Application 6 North America 6.1 North America Antidiabetic Thiazolidinediones by Countries 6.1.1 North America Antidiabetic Thiazolidinediones Sales by Countries 6.1.2 North America Antidiabetic Thiazolidinediones Revenue by Countries 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Antidiabetic Thiazolidinediones by Type 6.3 North America Antidiabetic Thiazolidinediones by Application 6.4 North America Antidiabetic Thiazolidinediones by Company 7 Europe 7.1 Europe Antidiabetic Thiazolidinediones by Countries 7.1.1 Europe Antidiabetic Thiazolidinediones Sales by Countries 7.1.2 Europe Antidiabetic Thiazolidinediones Revenue by Countries 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Antidiabetic Thiazolidinediones by Type 7.3 Europe Antidiabetic Thiazolidinediones by Application 7.4 Europe Antidiabetic Thiazolidinediones by Company 8 Asia Pacific 8.1 Asia Pacific Antidiabetic Thiazolidinediones by Countries 8.1.1 Asia Pacific Antidiabetic Thiazolidinediones Sales by Countries 8.1.2 Asia Pacific Antidiabetic Thiazolidinediones Revenue by Countries 8.1.3 China 8.1.4 Japan 8.1.5 Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Malaysia 8.1.10 Philippines 8.1.11 Thailand 8.1.12 Vietnam 8.1.13 Singapore 8.2 Asia Pacific Antidiabetic Thiazolidinediones by Type 8.3 Asia Pacific Antidiabetic Thiazolidinediones by Application 8.4 Asia Pacific Antidiabetic Thiazolidinediones by Company 9 Central & South America 9.1 Central & South America Antidiabetic Thiazolidinediones by Countries 9.1.1 Central & South America Antidiabetic Thiazolidinediones Sales by Countries 9.1.2 Central & South America Antidiabetic Thiazolidinediones Revenue by Countries 9.1.3 Brazil 9.2 Central & South America Antidiabetic Thiazolidinediones by Type 9.3 Central & South America Antidiabetic Thiazolidinediones by Application 9.4 Central & South America Antidiabetic Thiazolidinediones by Company 10 Middle East and Africa 10.1 Middle East and Africa Antidiabetic Thiazolidinediones by Countries 10.1.1 Middle East and Africa Antidiabetic Thiazolidinediones Sales by Countries 10.1.2 Middle East and Africa Antidiabetic Thiazolidinediones Revenue by Countries 10.1.3 GCC Countries 10.1.4 Turkey 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Antidiabetic Thiazolidinediones by Type 10.3 Middle East and Africa Antidiabetic Thiazolidinediones by Application 10.4 Middle East and Africa Antidiabetic Thiazolidinediones by Company 11 Company Profiles 11.1 Sanofi 11.1.1 Sanofi Company Details 11.1.2 Company Description 11.1.3 Sales, Revenue and Gross Margin of Antidiabetic Thiazolidinediones 11.1.4 Antidiabetic Thiazolidinediones Product Description 11.1.5 Recent Development 11.2 Takeda Pharmaceuticals 11.2.1 Takeda Pharmaceuticals Company Details 11.2.2 Company Description 11.2.3 Sales, Revenue and Gross Margin of Antidiabetic Thiazolidinediones 11.2.4 Antidiabetic Thiazolidinediones Product Description 11.2.5 Recent Development 11.3 Eli Lilly 11.3.1 Eli Lilly Company Details 11.3.2 Company Description 11.3.3 Sales, Revenue and Gross Margin of Antidiabetic Thiazolidinediones 11.3.4 Antidiabetic Thiazolidinediones Product Description 11.3.5 Recent Development 11.4 Merck & Co. 11.4.1 Merck & Co. Company Details 11.4.2 Company Description 11.4.3 Sales, Revenue and Gross Margin of Antidiabetic Thiazolidinediones 11.4.4 Antidiabetic Thiazolidinediones Product Description 11.4.5 Recent Development 11.5 Novo Nordisk 11.5.1 Novo Nordisk Company Details 11.5.2 Company Description 11.5.3 Sales, Revenue and Gross Margin of Antidiabetic Thiazolidinediones 11.5.4 Antidiabetic Thiazolidinediones Product Description 11.5.5 Recent Development 11.6 Bristol-Myers Squibb 11.6.1 Bristol-Myers Squibb Company Details 11.6.2 Company Description 11.6.3 Sales, Revenue and Gross Margin of Antidiabetic Thiazolidinediones 11.6.4 Antidiabetic Thiazolidinediones Product Description 11.6.5 Recent Development 11.7 Pfizer 11.7.1 Pfizer Company Details 11.7.2 Company Description 11.7.3 Sales, Revenue and Gross Margin of Antidiabetic Thiazolidinediones 11.7.4 Antidiabetic Thiazolidinediones Product Description 11.7.5 Recent Development 11.8 AstraZeneca 11.8.1 AstraZeneca Company Details 11.8.2 Company Description 11.8.3 Sales, Revenue and Gross Margin of Antidiabetic Thiazolidinediones 11.8.4 Antidiabetic Thiazolidinediones Product Description 11.8.5 Recent Development 11.9 GlaxoSmithKline 11.9.1 GlaxoSmithKline Company Details 11.9.2 Company Description 11.9.3 Sales, Revenue and Gross Margin of Antidiabetic Thiazolidinediones 11.9.4 Antidiabetic Thiazolidinediones Product Description 11.9.5 Recent Development 11.10 Boehringer Ingelheim 11.10.1 Boehringer Ingelheim Company Details 11.10.2 Company Description 11.10.3 Sales, Revenue and Gross Margin of Antidiabetic Thiazolidinediones 11.10.4 Antidiabetic Thiazolidinediones Product Description 11.10.5 Recent Development 12 Market Opportunities, Challenges, Risks and Influences Factors Analysis 12.1 Market Opportunities and Drivers 12.2 Market Challenges 12.3 Market Risks/Restraints 12.4 Key World Economic Indicators 13 Value Chain and Sales Channels Analysis 13.1 Value Chain Analysis 13.1.1 Typical Suppliers of Key Antidiabetic Thiazolidinediones Raw Material 13.1.2 Antidiabetic Thiazolidinediones Customers 13.2 Sales Channels Analysis 13.2.1 Sales Channels Analysis 13.2.2 Distributors 14 Research Findings and Conclusion 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Author Details 15.3 Disclaimer

List of Tables and Figures Figure Picture of Antidiabetic Thiazolidinediones Figure Global Antidiabetic Thiazolidinediones Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2013-2025) Figure Global Antidiabetic Thiazolidinediones Production Market Share by Types (Product Category) in 2017 Figure Rosiglitazone Product Picture Table Major Manufacturers of Rosiglitazone Figure Pioglitazone Product Picture Table Major Manufacturers of Pioglitazone Table Global Antidiabetic Thiazolidinediones Market Size Growth Rate by Application 2018-2025 (K Pcs) Figure Hospitals Figure Clinics Figure Other Figure Antidiabetic Thiazolidinediones Report Years Considered Figure Global Antidiabetic Thiazolidinediones Market Size 2016-2025 (Million US$) Figure Global Antidiabetic Thiazolidinediones Sales 2016-2025 (K Pcs) Table Global Antidiabetic Thiazolidinediones Market Size by Regions 2016-2025 (K Pcs) & (Million US$) Table Global Antidiabetic Thiazolidinediones Sales by Regions 2016-2025 (K Pcs) Table Global Antidiabetic Thiazolidinediones Sales Market Share by Regions 2016-2025 Figure Global Antidiabetic Thiazolidinediones Sales Market Share by Regions 2016-2025 Figure 2017 Global Antidiabetic Thiazolidinediones Sales Market Share by Regions Table Global Antidiabetic Thiazolidinediones Revenue by Regions 2016-2025 (Million US$) Table Global Antidiabetic Thiazolidinediones Revenue Market Share by Regions 2016-2025 Figure Global Antidiabetic Thiazolidinediones Revenue Market Share by Regions 2016-2025 Figure 2017 Global Antidiabetic Thiazolidinediones Revenue Market Share by Regions Table Global Antidiabetic Thiazolidinediones Sales by Manufacturers (2016-2018) (K Pcs) Table Global Antidiabetic Thiazolidinediones Sales Share by Manufacturers (2016-2018) Figure Global Antidiabetic Thiazolidinediones Sales Share by Manufacturers in 2017 Table Antidiabetic Thiazolidinediones Revenue by Manufacturers (2016-2018) (Million US$) Table Antidiabetic Thiazolidinediones Revenue Share by Manufacturers (2016-2018) Figure Antidiabetic Thiazolidinediones Value Share by Manufacturers in 2017 Table Global Antidiabetic Thiazolidinediones Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Manufacturers Antidiabetic Thiazolidinediones Price (2016-2018) (USD/Pcs) Table Antidiabetic Thiazolidinediones Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Antidiabetic Thiazolidinediones Product Category Table Date of International Manufacturers Enter into Antidiabetic Thiazolidinediones Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Antidiabetic Thiazolidinediones Sales by Type (2016-2025) (K Pcs) Table Global Antidiabetic Thiazolidinediones Sales Share by Type (2016-2025) Figure Global Antidiabetic Thiazolidinediones Sales Market Share by Type (2016-2025) Figure Global Antidiabetic Thiazolidinediones Sales Market Share by Type in 2017 Table Global Antidiabetic Thiazolidinediones Revenue by Type (2016-2025) (Million US$) Table Global Antidiabetic Thiazolidinediones Revenue Share by Type (2016-2025) Figure Global Antidiabetic Thiazolidinediones Revenue Market Share by Type (2016-2025) Figure Global Antidiabetic Thiazolidinediones Revenue Market Share by Type in 2017 Table Antidiabetic Thiazolidinediones Price by Type 2013-2018 (USD/Pcs) Table Global Antidiabetic Thiazolidinediones Sales by Application (2016-2025) (K Pcs) Table Global Antidiabetic Thiazolidinediones Sales Share by Application (2016-2025) Figure Global Sales Antidiabetic Thiazolidinediones Market Share by Application (2016-2025) Figure Global Sales Antidiabetic Thiazolidinediones Market Share by Application (2016-2025) Figure North America Antidiabetic Thiazolidinediones Sales Growth Rate 2016-2025 (K Pcs) Figure North America Antidiabetic Thiazolidinediones Revenue Growth Rate 2016-2025 (Million US$) Table North America Antidiabetic Thiazolidinediones Sales by Countries (2016-2025) (K Pcs) Table North America Antidiabetic Thiazolidinediones Sales Market Share by Countries (2016-2025) Figure 2017 North America Antidiabetic Thiazolidinediones Sales Market Share by Countries Table North America Antidiabetic Thiazolidinediones Revenue by Countries (2016-2025) (Million US$) Table North America Antidiabetic Thiazolidinediones Revenue Market Share by Countries (2016-2025) Figure 2017 North America Antidiabetic Thiazolidinediones Revenue Market Share by Countries Figure United States Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure United States Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (Million US$) Figure Canada Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure Canada Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (Million US$) Figure Mexico Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure Mexico Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (Million US$) Table North America Antidiabetic Thiazolidinediones Sales by Type (2016-2025) (K Pcs) Table North America Antidiabetic Thiazolidinediones Sales Market Share by Type (2016-2025) Figure 2017 North America Antidiabetic Thiazolidinediones Market Share by Type Table North America Antidiabetic Thiazolidinediones Sales by Application (2016-2025) (K Pcs) Table North America Antidiabetic Thiazolidinediones Sales Market Share by Application (2016-2025) Figure 2017 North America Antidiabetic Thiazolidinediones Market Share by Application Table North America Antidiabetic Thiazolidinediones Sales by Company (2016-2018) (K Pcs) Table North America Antidiabetic Thiazolidinediones Sales Market Share by Company (2016-2018) Figure North America Antidiabetic Thiazolidinediones Sales Market Share by Company in 2017 Figure Europe Antidiabetic Thiazolidinediones Sales Growth Rate 2016-2025 (K Pcs) Figure Europe Antidiabetic Thiazolidinediones Revenue Growth Rate 2016-2025 (Million US$) Table Europe Antidiabetic Thiazolidinediones Sales by Countries (2016-2025) (K Pcs) Table Europe Antidiabetic Thiazolidinediones Sales Market Share by Countries (2016-2025) Figure 2017 Europe Antidiabetic Thiazolidinediones Sales Market Share by Countries Table Europe Antidiabetic Thiazolidinediones Revenue by Countries (2016-2025) (Million US$) Table Europe Antidiabetic Thiazolidinediones Revenue Market Share by Countries (2016-2025) Figure 2017 Europe Antidiabetic Thiazolidinediones Revenue Market Share by Countries Figure Germany Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure Germany Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (K Pcs) Figure France Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure France Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (K Pcs) Figure UK Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure UK Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (Million US$) Figure Italy Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure Italy Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (Million US$) Figure Russia Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure Russia Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (Million US$) Table Europe Antidiabetic Thiazolidinediones Sales by Type (2016-2025) (K Pcs) Table Europe Antidiabetic Thiazolidinediones Sales Market Share by Type (2016-2025) Figure 2017 Europe Antidiabetic Thiazolidinediones Market Share by Type Table Europe Antidiabetic Thiazolidinediones Sales by Application (2016-2025) (K Pcs) Table Europe Antidiabetic Thiazolidinediones Sales Market Share by Application (2016-2025) Figure 2017 Europe Antidiabetic Thiazolidinediones Market Share by Application Table Europe Antidiabetic Thiazolidinediones Sales by Company (2016-2018) (K Pcs) Table Europe Antidiabetic Thiazolidinediones Sales Market Share by Company (2016-2018) Figure Europe Antidiabetic Thiazolidinediones Sales Market Share by Company in 2017 Figure Asia Pacific Antidiabetic Thiazolidinediones Sales Growth Rate 2016-2025 (K Pcs) Figure Asia Pacific Antidiabetic Thiazolidinediones Revenue Growth Rate 2016-2025 (Million US$) Table Asia Pacific Antidiabetic Thiazolidinediones Sales by Countries (2016-2025) (K Pcs) Table Asia Pacific Antidiabetic Thiazolidinediones Sales Market Share by Countries (2016-2025) Figure 2017 Asia Pacific Antidiabetic Thiazolidinediones Sales Market Share by Countries Table Asia Pacific Antidiabetic Thiazolidinediones Revenue by Countries (2016-2025) (Million US$) Table Asia Pacific Antidiabetic Thiazolidinediones Revenue Market Share by Countries (2016-2025) Figure 2017 Asia Pacific Antidiabetic Thiazolidinediones Revenue Market Share by Countries Figure China Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure China Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (Million US$) Figure Japan Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure Japan Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (Million US$) Figure Korea Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure Korea Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (Million US$) Figure India Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure India Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (Million US$) Figure Australia Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure Australia Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (Million US$) Figure Indonesia Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure Indonesia Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (Million US$) Figure Malaysia Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure Malaysia Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (Million US$) Figure Philippines Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure Philippines Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (Million US$) Figure Thailand Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure Thailand Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (Million US$) Figure Vietnam Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure Vietnam Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (Million US$) Figure Singapore Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure Singapore Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (Million US$) Table Asia Pacific Antidiabetic Thiazolidinediones Sales by Type (2016-2025) (K Pcs) Table Asia Pacific Antidiabetic Thiazolidinediones Sales Market Share by Type (2016-2025) Figure 2017 Asia Pacific Antidiabetic Thiazolidinediones Market Share by Type Table Asia Pacific Antidiabetic Thiazolidinediones Sales by Application (2016-2025) (K Pcs) Table Asia Pacific Antidiabetic Thiazolidinediones Sales Market Share by Application (2016-2025) Figure 2017 Asia Pacific Antidiabetic Thiazolidinediones Market Share by Application Table Asia Pacific Antidiabetic Thiazolidinediones Sales by Company (2016-2018) (K Pcs) Table Asia Pacific Antidiabetic Thiazolidinediones Sales Market Share by Company (2016-2018) Figure Asia Pacific Antidiabetic Thiazolidinediones Sales Market Share by Company in 2017 Figure Central & South America Antidiabetic Thiazolidinediones Sales Growth Rate 2016-2025 (K Pcs) Figure Central & South America Antidiabetic Thiazolidinediones Revenue Growth Rate 2016-2025 (Million US$) Table Central & South America Antidiabetic Thiazolidinediones Sales by Countries (2016-2025) (K Pcs) Table Central & South America Antidiabetic Thiazolidinediones Sales Market Share by Countries (2016-2025) Figure 2017 Central & South America Antidiabetic Thiazolidinediones Sales Market Share by Countries Table Central & South America Antidiabetic Thiazolidinediones Revenue by Countries (2016-2025) (Million US$) Table Central & South America Antidiabetic Thiazolidinediones Revenue Market Share by Countries (2016-2025) Figure 2017 Central & South America Antidiabetic Thiazolidinediones Revenue Market Share by Countries Figure Brazil Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure Brazil Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (Million US$) Figure Argentina Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure Argentina Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (Million US$) Table Central & South America Antidiabetic Thiazolidinediones Sales by Type (2016-2025) (K Pcs) Table Central & South America Antidiabetic Thiazolidinediones Sales Market Share by Type (2016-2025) Figure 2017 Central & South America Antidiabetic Thiazolidinediones Market Share by Type Table Central & South America Antidiabetic Thiazolidinediones Sales by Application (2016-2025) (K Pcs) Table Central & South America Antidiabetic Thiazolidinediones Sales Market Share by Application (2016-2025) Figure 2017 Central & South America Antidiabetic Thiazolidinediones Market Share by Application Table Central & South America Antidiabetic Thiazolidinediones Sales by Company (2016-2018) (K Pcs) Table Central & South America Antidiabetic Thiazolidinediones Sales Market Share by Company (2016-2018) Figure Central & South America Antidiabetic Thiazolidinediones Sales Market Share by Company in 2017 Figure Middle East and Africa Antidiabetic Thiazolidinediones Sales Growth Rate 2016-2025 (K Pcs) Figure Middle East and Africa Antidiabetic Thiazolidinediones Revenue Growth Rate 2016-2025 (Million US$) Table Middle East and Africa Antidiabetic Thiazolidinediones Sales by Countries (2016-2025) (K Pcs) Table Middle East and Africa Antidiabetic Thiazolidinediones Sales Market Share by Countries (2016-2025) Figure 2017 Middle East and Africa Antidiabetic Thiazolidinediones Sales Market Share by Countries Table Middle East and Africa Antidiabetic Thiazolidinediones Revenue by Countries (2016-2025) (Million US$) Table Middle East and Africa Antidiabetic Thiazolidinediones Revenue Market Share by Countries (2016-2025) Figure 2017 Middle East and Africa Antidiabetic Thiazolidinediones Revenue Market Share by Countries Figure GCC Countries Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure GCC Countries Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (Million US$) Figure Turkey Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure Turkey Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (Million US$) Figure Egypt Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure Egypt Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (Million US$) Figure South Africa Antidiabetic Thiazolidinediones Sales Growth Rate (2016-2025) (K Pcs) Figure South Africa Antidiabetic Thiazolidinediones Revenue Growth Rate (2016-2025) (Million US$) Table Middle East and Africa Antidiabetic Thiazolidinediones Sales by Type (2016-2025) (K Pcs) Table Middle East and Africa Antidiabetic Thiazolidinediones Sales Market Share by Type (2016-2025) Figure 2017 Middle East and Africa Antidiabetic Thiazolidinediones Market Share by Type Table Middle East and Africa Antidiabetic Thiazolidinediones Sales by Application (2016-2025) (K Pcs) Table Middle East and Africa Antidiabetic Thiazolidinediones Sales Market Share by Application (2016-2025) Figure 2017 Middle East and Africa Antidiabetic Thiazolidinediones Market Share by Application Table Middle East and Africa Antidiabetic Thiazolidinediones Sales by Company (2016-2018) (K Pcs) Table Middle East and Africa Antidiabetic Thiazolidinediones Sales Market Share by Company (2016-2018) Figure Middle East and Africa Antidiabetic Thiazolidinediones Sales Market Share by Company in 2017 Table Sanofi Company Details Table Sanofi Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018) Table Sanofi Recent Development Table Takeda Pharmaceuticals Company Details Table Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018) Table Takeda Pharmaceuticals Recent Development Table Eli Lilly Company Details Table Eli Lilly Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018) Table Eli Lilly Recent Development Table Merck & Co. Company Details Table Merck & Co. Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018) Table Merck & Co. Recent Development Table Novo Nordisk Company Details Table Novo Nordisk Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018) Table Novo Nordisk Recent Development Table Bristol-Myers Squibb Company Details Table Bristol-Myers Squibb Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018) Table Bristol-Myers Squibb Recent Development Table Pfizer Company Details Table Pfizer Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018) Table Pfizer Recent Development Table AstraZeneca Company Details Table AstraZeneca Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018) Table AstraZeneca Recent Development Table GlaxoSmithKline Company Details Table GlaxoSmithKline Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018) Table GlaxoSmithKline Recent Development Table Boehringer Ingelheim Company Details Table Boehringer Ingelheim Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2018) Table Boehringer Ingelheim Recent Development Figure GDP by Regions / Largest Economies Pie Chart in 2016 Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060 Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016 Figure Saving Rate Total, % of GDP, 2015 Table Antidiabetic Thiazolidinediones Value Chain Table Typical Suppliers of Key Antidiabetic Thiazolidinediones Raw Material Table Antidiabetic Thiazolidinediones Customers List Table Antidiabetic Thiazolidinediones Sales Channels Table Antidiabetic Thiazolidinediones Distributors List Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources